Extended-spectrum beta-lactamases: the role of inhibitors in therapy.
Amyes
S G
SG
Department of Medical Microbiology, The Medical School, University of Edinburgh, UK. s.g.b.amyes@ed.ac.uk
Miles
R S
RS
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001419:Bacteria / Q000187:drug effects / Q000201:enzymology; D001424:Bacterial Infections / Q000188:drug therapy* / Q000382:microbiology; D003428:Cross Infection / Q000188:drug therapy; D004352:Drug Resistance, Microbial; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D006801:Humans; D009154:Mutation; D065093:beta-Lactamase Inhibitors; D001618:beta-Lactamases / Q000235:genetics
D000900:Anti-Bacterial Agents; D004791:Enzyme Inhibitors; D065093:beta-Lactamase Inhibitors; D001618:beta-Lactamases